506 related articles for article (PubMed ID: 1458763)
21. Stereoselective plasma protein binding and target tissue distribution of clausenamide enantiomers in rats.
Zhu CJ; Zhang JT
Chirality; 2009 Mar; 21(3):402-6. PubMed ID: 18655159
[TBL] [Abstract][Full Text] [Related]
22. Stereoselective pharmacokinetics of cetirizine in the guinea pig: role of protein binding.
Gupta A; Hammarlund-Udenaes M; Chatelain P; Massingham R; Jonsson EN
Biopharm Drug Dispos; 2006 Sep; 27(6):291-7. PubMed ID: 16791848
[TBL] [Abstract][Full Text] [Related]
23. Plasma protein binding of propranolol enantiomers as a major determinant of their stereoselective tissue distribution in rats.
Takahashi H; Ogata H; Kanno S; Takeuchi H
J Pharmacol Exp Ther; 1990 Jan; 252(1):272-8. PubMed ID: 2299595
[TBL] [Abstract][Full Text] [Related]
24. [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].
Tillement JP; Duché JC; Barré J
Bull Acad Natl Med; 2006; 190(4-5):935-46; discussion 946-7. PubMed ID: 17195618
[TBL] [Abstract][Full Text] [Related]
25. Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Lombardo F; Obach RS; Shalaeva MY; Gao F
J Med Chem; 2004 Feb; 47(5):1242-50. PubMed ID: 14971904
[TBL] [Abstract][Full Text] [Related]
26. Plasma Protein Binding of Highly Bound Drugs Determined With Equilibrium Gel Filtration of Nonradiolabeled Compounds and LC-MS/MS Detection.
Isbell J; Yuan D; Torrao L; Gatlik E; Hoffmann L; Wipfli P
J Pharm Sci; 2019 Feb; 108(2):1053-1060. PubMed ID: 30336155
[TBL] [Abstract][Full Text] [Related]
27. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
Deshmukh SV; Harsch A
J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
[TBL] [Abstract][Full Text] [Related]
28. Protein binding of drugs in plasma, interstitial fluid and tissues: effect on pharmacokinetics.
Faed EM
Eur J Clin Pharmacol; 1981; 21(1):77-81. PubMed ID: 7333350
[TBL] [Abstract][Full Text] [Related]
29. The bioanalytical challenge of determining unbound concentration and protein binding for drugs.
Nilsson LB
Bioanalysis; 2013 Dec; 5(24):3033-50. PubMed ID: 24320129
[TBL] [Abstract][Full Text] [Related]
30. Determination of compound binding to plasma proteins.
Dow N
Curr Protoc Pharmacol; 2006 Oct; Chapter 7():Unit7.5. PubMed ID: 22294178
[TBL] [Abstract][Full Text] [Related]
31. [The prediction of enantiomeric differences in the pharmacokinetic parameters of drugs by using a physiological perfusion model].
Piotrovskiĭ VK; Shvachko EV; Trnovec T
Eksp Klin Farmakol; 1994; 57(5):37-40. PubMed ID: 7696904
[TBL] [Abstract][Full Text] [Related]
32. Impact of pH on plasma protein binding in equilibrium dialysis.
Kochansky CJ; McMasters DR; Lu P; Koeplinger KA; Kerr HH; Shou M; Korzekwa KR
Mol Pharm; 2008; 5(3):438-48. PubMed ID: 18345638
[TBL] [Abstract][Full Text] [Related]
33. In-depth insight into the methods of plasma protein-drug interaction studies: Comparison of capillary electrophoresis-frontal analysis, isothermal titration calorimetry, circular dichroism and equilibrium dialysis.
Nevídalová H; Michalcová L; Glatz Z
Electrophoresis; 2018 Feb; 39(4):581-589. PubMed ID: 29110326
[TBL] [Abstract][Full Text] [Related]
34. Drug-protein-binding determination of stilbene glucoside using cloud-point extraction and comparison with ultrafiltration and equilibrium dialysis.
Wang C; Wang Q; Yuan Z; Liu W; Gu J; Zhang L
Drug Dev Ind Pharm; 2010 Mar; 36(3):307-14. PubMed ID: 19670965
[TBL] [Abstract][Full Text] [Related]
35. Impact of recovery on fraction unbound using equilibrium dialysis.
Di L; Umland JP; Trapa PE; Maurer TS
J Pharm Sci; 2012 Mar; 101(3):1327-35. PubMed ID: 22161810
[TBL] [Abstract][Full Text] [Related]
36. In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review.
Lambrinidis G; Vallianatou T; Tsantili-Kakoulidou A
Adv Drug Deliv Rev; 2015 Jun; 86():27-45. PubMed ID: 25819487
[TBL] [Abstract][Full Text] [Related]
37. Drug distribution and binding.
Oie S
J Clin Pharmacol; 1986; 26(8):583-6. PubMed ID: 3793947
[TBL] [Abstract][Full Text] [Related]
38. Disposition of ethopropazine enantiomers in the rat: tissue distribution and plasma protein binding.
Brocks DR; Maboudian-Esfahani M
J Pharm Pharm Sci; 1999; 2(1):23-9. PubMed ID: 10951659
[TBL] [Abstract][Full Text] [Related]
39. Improved Ultrafiltration Method to Measure Drug Release from Nanomedicines Utilizing a Stable Isotope Tracer.
Skoczen SL; Stern ST
Methods Mol Biol; 2018; 1682():223-239. PubMed ID: 29039106
[TBL] [Abstract][Full Text] [Related]
40. [Methods of determination, physico-chemical properties and pharmacokinetic signifance of plasma protein binding of drugs].
Krieglstein J
Arzneimittelforschung; 1973 Nov; 23(11):1527-9. PubMed ID: 4801656
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
